DaVita Inc.
BioSniper Score
Based on 4 of 6 signals
Market Cap
$13.34B
Cash Runway
12.4 mo
Lead Asset
dbb-05 hemodialysis delivery system
Next Catalyst
—
Tracking 2 pipeline candidates for DaVita Inc. · Updated within the last hour.
Go deeper on DaVita Inc. with Spotter
Ask follow-up questions and run a full multi-agent deep dive on DVA — live, with citations.
Score breakdownBased on 4 of 6 signals · derived from public data
12.4 months
OCF $321M · Net income $198M · Debt/OCF 7.6×
No tracked pipeline phase
2 candidates
No upcoming catalysts tracked
0 buys · 7 sells (180d)
Key Financialsas of March 31, 2026
Cash
$726.4M
Quarterly Burn
$421.9M
Revenue
$3.42B
Free Cash Flow
$320.8M
Total Liabilities
$16.45B
Shareholders Equity
-$755.5M
Current Ratio
1.42
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
Commercialization & Governance
Commercialization
- Launch Markets
- -
- Commercial Strategy
- Patient-centric care model leveraging platform of kidney care services to maximize patient choice in both models and modalities of care, with focus on comprehensive kidney care to support commitments to help improve equitable clinical outcomes and quality of life for patients
Governance
- Board Size
- 9
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
581
Total value held
$9.56B
| Holder | Shares | Value |
|---|---|---|
| berkshire hathaway inc | 30,100,585 | $4.63B |
| vanguard capital management llc | 4,360,450 | $670.2M |
| blackrock, inc. | 2,766,751 | $425.2M |
| morgan stanley | 1,666,038 | $256.1M |
| vanguard portfolio management llc | 1,479,600 | $227.4M |
| state street corp | 1,351,737 | $207.7M |
| dimensional fund advisors lp | 1,145,436 | $176.0M |
| arrowstreet capital, limited partnership | 1,110,151 | $170.6M |
| geode capital management, llc | 939,781 | $144.2M |
| woodline partners lp | 905,958 | $139.2M |
Showing top 10 of 581 institutional holders of DaVita Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
Who is the CEO of DaVita Inc.?
Mr. Javier J. Rodriguez is the chief executive officer of DaVita Inc. (DVA).
Where is DaVita Inc. headquartered?
DaVita Inc. (DVA) is headquartered in Denver, CO, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.
Get the full picture on DaVita Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.